Form D · Biotechnology

InCytu Inc

Lincoln, RI · CIK 0001415725

Offering snapshot reported Jan 12, 2012 · SEC filing

Reported sold
$1.86M
Offering amount: $1.86M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 12, 2012Initial$1,860,410No comparison11SEC filing
Aug 7, 2009Amendment$3,259,660$485,000vs Mar 31, 20094SEC filing
Mar 31, 2009Initial$2,774,660No comparisonNot reportedSEC filing
Feb 1, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Feb 1, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Oct 16, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-171734

Source: Form D, filed Jan 12, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Berenson Director, Executive
David Cohen Director
David Mooney Director
John G. Picerne Director
Alfred V Vasconcellos Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
701 George Washington Highway
Lincoln, RI, 02865